Rocephin

Company
Roche

Approval Status
Approved January 1998

Treatment for
Pediatric otitis media

Possible similar drugs
Rocephin

Areas
ENT (Ear, Nose and Throat) , Pediatrics

Hoffmann-LaRoche's antibiotic Rocephin (ceftriaxone sodium) has been approved as a one dose injection for the treatment of bacterial otitis media in children. The drug was previously approved for use as a 10-day multiple dose oral treatment.

In clinical trials involving 2.450 children demonstrated that the drug, when administered intramuscularly as a single dose, is comparable to standard 10-day multiple dose oral treatments. The injectable form was found to be 100% effective in eradicating Hemophilus influenzae, Moraxella catarrhalis and susceptible Streptococcus pneumoniae.

Rocephin_392 Drug Information

The Rocephin_392 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top